New weekly injection tested for rare Muscle-Weakening diseases

NCT ID NCT04033926

Summary

This study tested whether a weekly injection called KZR-616 could safely improve muscle strength and overall disease activity in adults with active polymyositis or dermatomyositis. Twenty-five participants received either the drug or a placebo for 16 weeks, then switched to the other treatment for another 16 weeks. Researchers measured changes in muscle strength, skin symptoms, and overall disease improvement scores.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DERMATOMYOSITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • KZR Research Site

    Beverly Hills, California, 90211, United States

  • KZR Research Site

    Orange, California, 92868, United States

  • KZR Research Site

    Miami, Florida, 33136, United States

  • KZR Research Site

    Atlanta, Georgia, 30322, United States

  • KZR Research Site

    Kansas City, Kansas, 66160, United States

  • KZR Research Site

    Baltimore, Maryland, 21224, United States

  • KZR Research Site

    Ann Arbor, Michigan, 48109, United States

  • KZR Research Site

    Great Neck, New York, 11021, United States

  • KZR Research Site

    Duncansville, Pennsylvania, 16635, United States

  • KZR Research Site

    Pittsburgh, Pennsylvania, 15213, United States

  • KZR Research Site

    Austin, Texas, 78756, United States

  • KZR Research Site

    Henrico, Virginia, 23233, United States

  • KZR Research Site

    Prague, Czechia

  • KZR Research Site

    Göttingen, Germany

Conditions

Explore the condition pages connected to this study.